
Should you hold CV Sciences (cvsi) stock?
The consensus among Wall Street equities research analysts is that investors should "hold" CV Sciences stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CVSI, but not buy additional shares or sell existing shares. View analyst ratings for CV Sciences or view top-rated stocks.
Is CV Sciences efficiently growing its dividend?
CV Sciences does not have a long track record of dividend growth. In the past three months, CV Sciences insiders have not sold or bought any company stock. Only 6.80% of the stock of CV Sciences is held by insiders. Only 0.02% of the stock of CV Sciences is held by institutions.
What does cvsi stand for?
CV Sciences, Inc. (CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced the appointment of Dr. Paul Blake to its Board of Directors effective October 21, 2019. “We are very pleased to have Dr.
What are Wall Street's price targets for CV Sciences'stock?
3 Wall Street analysts have issued 12 month price objectives for CV Sciences' shares. Their predictions range from $5.00 to $9.00. On average, they anticipate CV Sciences' stock price to reach $7.33 in the next year.

How High Will CVSI stock go?
Their CVSI stock forecasts range from $0.17 to $0.17. On average, they expect CV Sciences' share price to reach $0.17 in the next twelve months. This suggests a possible upside of 431.3% from the stock's current price. View analysts' price targets for CV Sciences or view top-rated stocks among Wall Street analysts.
Is CVSI a good stock to buy?
The financial health and growth prospects of CVSI, demonstrate its potential to underperform the market. It currently has a Growth Score of A. Recent price changes and earnings estimate revisions indicate this would be a good stock for momentum investors with a Momentum Score of A.
What does CV Sciences do?
(OTCQB:CVSI) operates two distinct business segments: a consumer product division focused on manufacturing, marketing and selling plant-based dietary supplements and CBD products to a range of market sectors; and a drug development division focused on developing and commercializing CBD-based novel therapeutics.
Is plus CBD oil good?
These Plus CBD oil softgel capsules are good for having a full spectrum hemp extract. This extract will benefit the human's endocannabinoid system and, further, bring balance to mind and body. This plus CBD oil product is a top consideration for CBD users because of the full spectrum hemp extract in it.
Should I buy or sell CV Sciences stock right now?
2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CV Sciences in the last year. There are currently 2 hold ratings...
What is CV Sciences' stock price forecast for 2022?
2 brokerages have issued 1-year price targets for CV Sciences' stock. Their CVSI stock forecasts range from $0.17 to $0.17. On average, they antici...
How has CV Sciences' stock performed in 2022?
CV Sciences' stock was trading at $0.12 at the start of the year. Since then, CVSI shares have decreased by 62.5% and is now trading at $0.0450. V...
How were CV Sciences' earnings last quarter?
CV Sciences, Inc. (OTCMKTS:CVSI) issued its quarterly earnings results on Monday, May, 16th. The company reported ($0.02) EPS for the quarter, meet...
Who are CV Sciences' key executives?
CV Sciences' management team includes the following people: Mr. Joseph D. Dowling , CEO, Sec. & Director (Age 65, Pay $418.52k) Mr. Joerg Grasse...
Who are some of CV Sciences' key competitors?
Some companies that are related to CV Sciences include RegeneRx Biopharmaceuticals (RGRX) , Lotus Pharmaceuticals (LTUS) , Emerald Bioscience (E...
What other stocks do shareholders of CV Sciences own?
Based on aggregate information from My MarketBeat watchlists, some companies that other CV Sciences investors own include (CGC) , Aurora Cannabi...
What is CV Sciences' stock symbol?
CV Sciences trades on the OTCMKTS under the ticker symbol "CVSI."
How do I buy shares of CV Sciences?
Shares of CVSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBul...
About CV Sciences
Headlines
CV Sciences, Inc. engages in the development, manufacture, and sale of consumer and pharmaceutical products. It operates through the Consumer Products and Specialty Pharmaceutical segments. The Consumer Products segment includes manufacturing, marketing, and selling of hemp-based cannabidiol products through the PlusCBD brand.
CV Sciences (OTCMKTS:CVSI) Frequently Asked Questions
Is Medical Marijuana Really A Slippery Slope? CVSI Distribution Agreement with GNC
